https://ir.volition.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_18c183a7b720c8677f23ccd3cd6b911e/volitionrx/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.volition.com/news-events/press-releases/detail/898/volitionrx-limited-announces-second-quarter-2026-financial-results-and-business-update Thu, 13 Aug 26 16:10:00 -0400 https://ir.volition.com/news-events/press-releases/detail/898/volitionrx-limited-announces-second-quarter-2026-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/897/volition-demonstrates-utility-of-rapid-point-of-care-finger-prick-test-in-sepsis-patients Wed, 12 Aug 26 08:17:00 -0400 https://ir.volition.com/news-events/press-releases/detail/897/volition-demonstrates-utility-of-rapid-point-of-care-finger-prick-test-in-sepsis-patients https://ir.volition.com/news-events/press-releases/detail/896/volitionrx-limited-schedules-second-quarter-2026-earnings-conference-call-and-business-update Tue, 11 Aug 26 16:10:00 -0400 https://ir.volition.com/news-events/press-releases/detail/896/volitionrx-limited-schedules-second-quarter-2026-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/895/volition-reports-publication-of-first-peer-reviewed-paper-on-new-capture-seq-liquid-biopsy-technology Wed, 05 Aug 26 08:17:00 -0400 https://ir.volition.com/news-events/press-releases/detail/895/volition-reports-publication-of-first-peer-reviewed-paper-on-new-capture-seq-liquid-biopsy-technology https://ir.volition.com/news-events/press-releases/detail/894/volition-advances-nu-q-nets-platform-towards-commercialization Thu, 30 Jul 26 08:17:00 -0400 https://ir.volition.com/news-events/press-releases/detail/894/volition-advances-nu-q-nets-platform-towards-commercialization https://ir.volition.com/news-events/press-releases/detail/893/volitionrx-announces-data-showing-the-prognostic-value-of-its-nu-q-cancer-test Tue, 07 Jul 26 08:17:00 -0400 https://ir.volition.com/news-events/press-releases/detail/893/volitionrx-announces-data-showing-the-prognostic-value-of-its-nu-q-cancer-test https://ir.volition.com/news-events/press-releases/detail/892/volitionrx-announces-collaboration-with-sysmex Wed, 17 Jun 26 08:15:00 -0400 https://ir.volition.com/news-events/press-releases/detail/892/volitionrx-announces-collaboration-with-sysmex https://ir.volition.com/news-events/press-releases/detail/891/volitionrx-announces-pricing-of-4-6-million-public-offering Sun, 07 Jun 26 18:30:00 -0400 https://ir.volition.com/news-events/press-releases/detail/891/volitionrx-announces-pricing-of-4-6-million-public-offering https://ir.volition.com/news-events/press-releases/detail/890/volitionrx-files-new-patent-protecting-its-nu-q-nets-test-for-ebola-triage-and-treatment-monitoring Wed, 03 Jun 26 08:12:00 -0400 https://ir.volition.com/news-events/press-releases/detail/890/volitionrx-files-new-patent-protecting-its-nu-q-nets-test-for-ebola-triage-and-treatment-monitoring https://ir.volition.com/news-events/press-releases/detail/889/volitionrx-highlights-commercial-momentum-and-multi-pillar-execution-across-27-billion-total-addressable-markets Wed, 27 May 26 08:17:00 -0400 https://ir.volition.com/news-events/press-releases/detail/889/volitionrx-highlights-commercial-momentum-and-multi-pillar-execution-across-27-billion-total-addressable-markets